Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2009, Article ID 874126, 5 pages
http://dx.doi.org/10.1155/2009/874126
Research Article

Impact of the Pro12Ala Polymorphism of the PPAR-Gamma 2 Gene on Metabolic and Clinical Characteristics in the Palestinian Type 2 Diabetic Patients

1Department of Biochemistry and Molecular Biology, Medical School, Al-Quds University, East Jerusalem, Abu-Deis, P.O. Box 19356, Palestine
2Al-Quds Nutrition and Health Research Institute, Al-Quds University, East Jerusalem, P.O. Box 20760, Palestine

Received 14 June 2009; Revised 6 August 2009; Accepted 25 August 2009

Academic Editor: Mostafa Badr

Copyright © 2009 S. Ereqat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Freeman and R. D. Cox, “Type-2 diabetes: a cocktail of genetic discovery,” Human Molecular Genetics, vol. 15, supplement 2, pp. R202–R209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. H. F. Abdul-Rahim, A. Husseini, R. Giacaman, J. Jervell, and E. Bjertness, “Diabetes mellitus in an urban Palestinian population: prevalence and associated factors,” Eastern Mediterranean Health Journal, vol. 7, no. 1-2, pp. 67–78, 2001. View at Google Scholar · View at Scopus
  3. W. He, “PPARγ2Pro12Ala polymorphism and human health,” PPAR Research, vol. 2009, Article ID 849538, 15 pages, 2009. View at Publisher · View at Google Scholar
  4. M.-C. Cho, K. Lee, S.-G. Paik, and D.-Y. Yoon, “Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders,” PPAR Research, vol. 2008, Article ID 679137, 14 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Stumvoll and H. Häring, “The peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism,” Diabetes, vol. 51, no. 8, pp. 2341–2347, 2002. View at Google Scholar · View at Scopus
  6. S. S. Deeb, L. Fajas, M. Nemoto et al., “A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity,” Nature Genetics, vol. 20, no. 3, pp. 284–287, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Ek, G. Andersen, S. A. Urhammer et al., “Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) gene in relation to insulin sensitivity among glucose tolerant Caucasians,” Diabetologia, vol. 44, no. 9, pp. 1170–1176, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Mori, H. Ikegami, Y. Kawaguchi et al., “The Pro12Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes,” Diabetes, vol. 50, no. 4, pp. 891–894, 2001. View at Google Scholar · View at Scopus
  9. K. Hara, T. Okada, K. Tobe et al., “The Pro12Ala polymorphism in PPARγ2 may confer resistance to type 2 diabetes,” Biochemical and Biophysical Research Communications, vol. 271, no. 1, pp. 212–216, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Zeggini, J. R. C. Parkinson, S. Halford et al., “Examining the relationships between the Pro12Ala variant in PPARG and type 2 diabetes-related traits in UK samples,” Diabetic Medicine, vol. 22, no. 12, pp. 1696–1700, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ghoussaini, D. Meyre, S. Lobbens et al., “Implication of the Pro12Ala polymorphism of the PPAR-gamma2 gene in type 2 diabetes and obesity in the French population,” BMC Medical Genetics, vol. 6, article 11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. K. Hansen, E.-M. D. Nielsen, J. Ek et al., “Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 6, pp. 3629–3637, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Badii, A. Bener, M. Zirie et al., “Lack of association between the Pro12Ala polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in the Qatari consanguineous population,” Acta Diabetologica, vol. 45, no. 1, pp. 15–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Z. Bouassida, L. Chouchane, K. Jellouli et al., “The peroxisome proliterator activated receptorφ2 (PPARφ2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients,” Diabetes & Metabolism, vol. 31, no. 2, pp. 119–123, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Y. Oh, K. M. Min, J. H. Chung et al., “Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-γ2 in Korean diabetic and obese subjects,” The Journal of Clinical Endocrinology & Metabolism, vol. 85, no. 5, pp. 1801–1804, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  17. A. Johansen, D. P. Jensen, R. Bergholdt et al., “IRS1, KCNJ11, PPARγ2 and HNF-1α: do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?” Diabetes, Obesity and Metabolism, vol. 8, no. 1, pp. 75–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. E. S. Tai, D. Corella, M. Deurenberg-Yap et al., “Differential effects of the C1431T and Pro12Ala PPARγ gene variants on plasma lipids and diabetes risk in an Asian population,” Journal of Lipid Research, vol. 45, no. 4, pp. 674–685, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Zietz, N. Barth, D. Spiegel, G. Schmitz, J. Schölmerich, and A. Schäffler, “Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 (PPARγ2) is associated with higher levels of total cholesterol and LDL-cholesterol in male Caucasian type 2 diabetes patients,” Experimental and Clinical Endocrinology and Diabetes, vol. 110, no. 2, pp. 60–66, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Ringel, S. Engeli, A. Distler, and A. M. Sharma, “Pro12Ala missense mutation of the peroxisome proliferator activated receptor γ and diabetes mellitus,” Biochemical and Biophysical Research Communications, vol. 254, no. 2, pp. 450–453, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Thamer, M. Haap, A. Volk et al., “Evidence for greater oxidative substrate flexibility in male carriers of the Pro 12 Ala polymorphism in PPARγ2,” Hormone and Metabolic Research, vol. 34, no. 3, pp. 132–136, 2002. View at Google Scholar · View at Scopus
  22. R. A. DeFronzo, J. D. Tobin, and R. Andres, “Glucose clamp technique: a method for quantifying insulin secretion and resistance,” The American Journal of Physiology, vol. 237, no. 3, pp. E214–E223, 1979. View at Google Scholar · View at Scopus
  23. T. O. Kilpeläinen, T. A. Lakka, D. E. Laaksonen et al., “SNPs in PPARG associate with type 2 diabetes and interact with physical activity,” Medicine and Science in Sports & Exercise, vol. 40, no. 1, pp. 25–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Schneider, J. Kreuzer, A. Hamann, P. P. Nawroth, and K. A. Dugi, “The Proline 12 substitution in the peroxisome proliferator-activated receptor-γ2 gene is associated with lower lipoprotein lipase activity in vivo,” Diabetes, vol. 51, no. 3, pp. 867–870, 2002. View at Google Scholar · View at Scopus
  25. F. P. Mancini, O. Vaccaro, L. Sabatino et al., “Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes,” Diabetes, vol. 48, no. 7, pp. 1466–1468, 1999. View at Publisher · View at Google Scholar · View at Scopus